Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Clinical Trials
3 recruiting trials for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD). Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT07202494
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience...
The MESO7 study is a prospective observational research project designed to investigate the mechanisms of resilience and neurodegeneration in neurological diseases and healthy...
Sponsor: Assistance Publique Hopitaux De MarseilleEnrolling: 7001 location
RECRUITINGEarly Phase 1NCT04561557
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous...
Antibody-mediated inflammatory diseases of the nervous system (also known as autoimmune diseases of the nervous system) are autoimmune diseases in which autoimmune cells and...
Sponsor: Tongji HospitalEnrolling: 361 location
RECRUITINGNCT05017142
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an inflammatory brain...
Sponsor: University of BernEnrolling: 50013 locations